본문 바로가기
KERD
논문KCI 등재

전기경련치료 효능의 최적화

Optimizing the Efficacy of Electroconvulsive Therapy

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Modern electroconvulsive therapy (ECT) is a non-pharmacological and biological treatment that is clinically effective and safe. ECT is used in the treatment of many psychiatric disorders, some neurological diseases, and psychiatric emergencies requiring a rapid and life-saving clinical response. Generalized seizures of the central nervous system induced by the electrical stimulation of ECT are an essential component of the therapeutic effects, which are attributed to the various neuronal responses of the brain. Modern ECT is conducted under general anesthesia, given to the extent of loss of consciousness, followed by administration of a muscle relaxant, and ECT with minimally appropriate electrical stimulation. ECT optimization has the main objective of ensuring maximum clinical efficacy and safety with minimal adverse events through adequate generalized seizures. Since its first introduction in clinical practice in 1938, many studies have been carried out and advances made to enhance the therapeutic effects of ECT and address the adverse events associated with it. As a result, there have been developments such as the use of a square wave instead of a sine wave, various electrode placements, dose titration methods, seizure thresholds, general anesthesia with muscle relaxation, session scheduling, monitoring of electroencephalograms (EEG) and electromyograms, etc. and these have been applied to actual clinical practice. Research on the clinical characteristics and the optimal ECT parameters to increase the efficacy of seizures is still ongoing. In this review, various factors associated with ECT such as EEG monitoring, motor seizures, electrode placements, stimulation dose and titration, seizure evaluation and adequacy, and the ECT algorithms are discussed to improve the efficacy of modern ECT as a useful treatment for psychiatric disorders.

Abstract

Modern electroconvulsive therapy (ECT) is a non-pharmacological and biological treatment that is clinically effective and safe. ECT is used in the treatment of many psychiatric disorders, some neurological diseases, and psychiatric emergencies requiring a rapid and life-saving clinical response. Generalized seizures of the central nervous system induced by the electrical stimulation of ECT are an essential component of the therapeutic effects, which are attributed to the various neuronal responses of the brain. Modern ECT is conducted under general anesthesia, given to the extent of loss of consciousness, followed by administration of a muscle relaxant, and ECT with minimally appropriate electrical stimulation. ECT optimization has the main objective of ensuring maximum clinical efficacy and safety with minimal adverse events through adequate generalized seizures. Since its first introduction in clinical practice in 1938, many studies have been carried out and advances made to enhance the therapeutic effects of ECT and address the adverse events associated with it. As a result, there have been developments such as the use of a square wave instead of a sine wave, various electrode placements, dose titration methods, seizure thresholds, general anesthesia with muscle relaxation, session scheduling, monitoring of electroencephalograms (EEG) and electromyograms, etc. and these have been applied to actual clinical practice. Research on the clinical characteristics and the optimal ECT parameters to increase the efficacy of seizures is still ongoing. In this review, various factors associated with ECT such as EEG monitoring, motor seizures, electrode placements, stimulation dose and titration, seizure evaluation and adequacy, and the ECT algorithms are discussed to improve the efficacy of modern ECT as a useful treatment for psychiatric disorders.

참고문헌 (211)

  1. Dubovsky SL, "Comprehensive textbook of psychiatry", pp.2129~2140 (1995), Lippincott Williams & Wilkins
  2. Faedda GL, "The origins of electroconvulsive therapy: Prof. Bini’s first report on ECT", J Affect Disord, 120, pp.12~15 (2010)
  3. Krystal AD, "ECT seizure therapeutic adequacy", Convuls Ther, 10, pp.153~164 (1994)
  4. Youn T, "Principles and practice of electroconvulsive therapy", pp.201~229 (2019), Seoul National University Publication Center
  5. Ingram WM, "Factors affecting electroconvulsive therapy ictal outcomes : duration and postictal suppression", AMIA Jt Summits Transl Sci Proc, 2019, pp.672~679 (2019)
  6. Tedeschi EA, "Factors associated with seizure adequacy along the course of electroconvulsive therapy", J ECT, 37, pp.46~50 (2021)
  7. de Arriba-Arnau A, "Factors predicting ictal quality in bilateral electroconvulsive therapy sessions", Brain Sci, 11, pp.781~ (2021)
  8. Bryson EO, "Individualized anesthetic management for patients undergoing electroconvulsive therapy : a review of current practice", Anesth Analg, 124, pp.1943~1956 (2017)
  9. Wajima Z, "Anesthesia management of special patient populations undergoing electroconvulsive therapy : a review", J Nippon Med Sch, 86, pp.70~80 (2019)
  10. Ottosson JO, "Experimental studies of the mode of action of electroconvulsive therapy : introduction", Acta Psychiatr Scand Suppl, 35, pp.5~6 (1960)
  11. Fink M, "Monitoring the duration of electroconvulsive therapy seizures : ‘cuff’ and EEG methods compared", Arch Gen Psychiatry, 39, pp.1189~1191 (1982)
  12. Abrams R, "Electroconvulsive therapy" (2002), Oxford University Press
  13. American Psychiatric Association, "The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (a task force report of the American Psychiatric Association)" (2001), American Psychiatric Association
  14. Sackeim HA, "Studies of dosage, seizure threshold, and seizure duration in ECT", Biol Psychiatry, 22, pp.249~268 (1987)
  15. Weiner RD, "The monitoring and management of electrically induced seizures", Psychiatr Clin North Am, 14, pp.845~869 (1991)
  16. Kellner CH, "Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression : a multisite study from the consortium for research in electroconvulsive therapy(CORE)", Arch Gen Psychiatry, 63, pp.1337~1344 (2006)
  17. Kellner CH, "Electrode placement in electroconvulsive therapy(ECT) : a review of the literature", J ECT, 26, pp.175~180 (2010)
  18. Sackeim HA, "Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy", N Engl J Med, 328, pp.839~846 (1993)
  19. Sackeim HA, "A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities", Arch Gen Psychiatry, 57, pp.425~434 (2000)
  20. Sackeim HA, "Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy", Brain Stimul, 1, pp.71~83 (2008)
  21. Rasmussen KG, "Principles and practice of electroconvulsive therapy", pp.101~129 (2019), American Psychiatric Association Publishing
  22. Weiner RD, "Clinical manual of electroconvulsive therapy", pp.59~79 (2010), American Psychiatric Publishing, Inc
  23. Scott A, "The ECT handbook: the second report of the Royal College of Psychiatrists’Special Committee on ECT", pp.62~66 (1995), Royal College of Psychiatrists
  24. Dunne RA, "The ECT handbook", pp.183~201 (2019), Cambridge University Press
  25. Kales H, "Relationship of seizure duration to antidepressant efficacy in electroconvulsive therapy", Psychol Med, 27, pp.1373~1380 (1997)
  26. Chung KF, "Relationships between seizure duration and seizure threshold and stimulus dosage at electroconvulsive therapy : implications for electroconvulsive therapy practice", Psychiatry Clin Neurosci, 56, pp.521~526 (2002)
  27. Sackeim HA, "The anticonvulsant hypothesis of the mechanisms of action of ECT : current status", J ECT, 15, pp.5~26 (1999)
  28. Luccarelli J, "Changes in seizure duration during acute course electroconvulsive therapy", Brain Stimul, 14, pp.941~946 (2021)
  29. Sackeim HA, "and seizure duration : impact on the efficacy and safety of electroconvulsive therapy", Psychiatr Clin North Am, 14, pp.803~843 (1991)
  30. Krueger RB, "Does ECT permanently alter seizure threshold?", Biol Psychiatry, 33, pp.272~276 (1993)
  31. Wild B, "Electroconvulsive therapy dosage in continuation", maintenance electroconvulsive therapy : when is a new threshold titration necessary?, 2004, pp.20, 200~203
  32. Semple D., "Pragmatic guidance for EEG interpretation", pp.6~12 (2017), David Semple
  33. Ueda S, "Determination of seizure adequacy and methods of stimulus dosing are essential for the clinical practice of pulse-wave ECT", Jpn J Gen Hosp Psychiatry, 24, pp.118~126 (2012)
  34. Nobler MS, "EEG manifestations during ECT : effects of electrode placement and stimulus intensity", Biol Psychiatry, 34, pp.321~330 (1993)
  35. Mayur P, "Ictal electroencephalographic characteristics during electroconvulsive therapy : a review of determination and clinical relevance", J ECT, 22, pp.213~217 (2006)
  36. Sawayama E, "The technique of electroconvulsive therapy for best effect", Jpn J Biol Psychiatry, 29, pp.143~146 (2018)
  37. Mankad MV, "Clinical manual of electroconvulsive therapy" (2010), American Psychiatric Publishing
  38. Scott AI, "Monitoring electroconvulsive therapy by electroencephalogram : an update for ECT practitioners", Adv Psychiatr Treat, 13, pp.298~304 (2007)
  39. Larson G, "Duration of ECT-induced tachycardia as a measure of seizure length", Am J Psychiatry, 141, pp.1269~1271 (1984)
  40. Swartz CM, "Endpoint of ECT-induced elevation in heart rate", J ECT, 15, pp.125~128 (1999)
  41. Mesbah M, "Automatic seizure detection based on the combination of newborn multi-channel EEG and HRV information", EURASIP J Adv Signal Process, 2012, pp.215~ (2012)
  42. Ranganath RD, "ECT and heart rate changes : an alternative to EEG monitoring for seizure confirmation during modified ECT", Ger J Psychiatry, 6, pp.60~63 (2003)
  43. 김은영, "The Determination of the Duration of Electroconvulsive Therapy-Induced Seizure Using Local Standard Deviation of the Electroencephalogram Signal and the Changes of the RR Interval of Electrocardiogram", 생물정신의학, 27(1), pp.1~8 (2020), 대한생물정신의학회[DOI]
  44. Semple DM, "The ECT handbook", pp.234~246 (2019), Cambridge University Press
  45. van Elmpt WJ, "A model of heart rate changes to detect seizures in severe epilepsy", Seizure, 15, pp.366~375 (2006)
  46. Opherk C, "Ictal heart rate differentiates epileptic from non-epileptic seizures", Neurology, 58, pp.636~638 (2002)
  47. Behbahani S, "Pre-ictal heart rate variability assessment of epileptic seizures by means of linear and non-linear analyses", Anadolu Kardiyol Derg, 13, pp.797~803 (2013)
  48. Osorio I, "Is seizure detection based on EKG clinically relevant?", Clin Neurophysiol, 125, pp.1946~1951 (2014)
  49. Jansen K, "Peri-ictal ECG changes in childhood epilepsy : implications for detection systems", Epilepsy Behav, 29, pp.72~76 (2013)
  50. Swartz CM, "Electroconvulsive and neuromodulation therapies", pp.477~484 (2009), Cambridge University Press
  51. Zijlmans M, "Heart rate changes and ECG abnormalities during epileptic seizures : prevalence and definition of an objective clinical sign", Epilepsia, 43, pp.847~854 (2002)
  52. Jeppesen J, "Detection of epileptic seizures with a modified heart rate variability algorithm based on Lorenz plot", Seizure, 24, pp.1~7 (2015)
  53. van Andel J, "Using photoplethysmography in heart rate monitoring of patients with epilepsy", Epilepsy Behav, 45, pp.142~145 (2015)
  54. Kerem DH, "Forecasting epilepsy from the heart rate signal", Med Biol Eng Comput, 43, pp.230~239 (2005)
  55. Swartz CM, "Heart rate differences between right and left unilateral electroconvulsive therapy", J Neurol Neurosurg Psychiatry, 57, pp.97~99 (1994)
  56. Ulate-Campos A, "Automated seizure detection systems and their effectiveness for each type of seizure", Seizure, 40, pp.88~101 (2016)
  57. Seong Hoon Jeong, "Initial Seizure Threshold in Brief-Pulse Bilateral Electroconvulsive Therapy in Patients with Schizophrenia or Schizoaffective Disorder", PSYCHIATRY INVESTIGATION, 16(9), pp.704~712 (2019), 대한신경정신의학회[DOI]
  58. Petrides G, "Seizure threshold in a large sample : implications for stimulus dosing strategies in bilateral electroconvulsive therapy : a report from CORE", J ECT, 25, pp.232~237 (2009)
  59. Seshadri M, "Response predictors in ECT : a discussion about seizure threshold", Br J Med Pract, 4, pp.a424~ (2011)
  60. 김효섭, "극단파 우측 단측성 전기경련치료의 초기 경련 역치", 신경정신의학, 59(4), pp.311~318 (2020), 대한신경정신의학회[DOI]
  61. Krystal AD, "Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings", J Neuropsychiatry Clin Neurosci, 10, pp.178~186 (1998)
  62. Krystal AD, "The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT", J ECT, 16, pp.338~349 (2000)
  63. Krystal AD, "Clinical manual of electroconvulsive therapy", pp.149~157 (2010), American Psychiatric Publishing, Inc
  64. Kellner CH, "Handbook of ECT: a guide to electroconvulsive therapy for practitioners" (2019), Cambridge University Press
  65. Scott AIF, "The ECT handbook: the third report of the Royal College of Psychiatrists’Special Committee on ECT", pp.144~158 (2005), Royal College of Psychiatrists
  66. MacPherson RD, "Low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy", J Affect Disord, 126, pp.330~333 (2010)
  67. Bergsholm P, "Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen", Acta Psychiatr Scand, 69, pp.121~128 (1984)
  68. Chater SN, "Effect of passive hyperventilation on seizure duration in patients undergoing electroconvulsive therapy", Br J Anaesth, 60, pp.70~73 (1988)
  69. Mayur P, "Impact of hyperventilation on stimulus efficiency during the early phase of an electroconvulsive therapy course : a randomized double-blind study", J ECT, 26, pp.91~94 (2010)
  70. Pande AC, "Effect of hyperventilation on seizure length during electroconvulsive therapy", Biol Psychiatry, 27, pp.799~801 (1990)
  71. Goh SE, "Selecting right unilateral placement to facilitate continuation of electroconvulsive therapy following prolonged seizures", Asian J Psychiatr, 66, pp.102874~ (2021)
  72. Bailine SH, "Indications for the use of propofol in electroconvulsive therapy", J ECT, 19, pp.129~132 (2003)
  73. Rattehalli RD, "Measuring electroencephalographic seizure adequacy during electroconvulsive therapy : a comparison of 2 definitions", J ECT, 25, pp.243~245 (2009)
  74. Egashira K, "Algorithm of electroconvulsive therapy using ictal—electroencephalogram", Jpn J Biol Psychiatry, 22, pp.207~211 (2011)
  75. Kranaster L, "Bispectral index monitoring and seizure quality optimization in electroconvulsive therapy", Pharmacopsychiatry, 46, pp.147~150 (2013)
  76. Aksay SS, "New evidence for seizure quality improvement by hyperoxia and mild hypocapnia", J ECT, 30, pp.287~291 (2014)
  77. Minelli A, "Seizure adequacy markers and the prediction of electroconvulsive therapy response", J ECT, 32, pp.88~92 (2016)
  78. Nishikawa K, "Effects of the concurrent use of a reduced dose of propofol with divided supplemental remifentanil and moderate hyperventilation on duration and morphology of electroconvulsive therapy-induced electroencephalographic seizure activity : a randomized controlled trial", J Clin Anesth, 37, pp.63~68 (2017)
  79. Watanabe T, "Predicting postictal suppression in electroconvulsive therapy using analysis of heart rate variability", J Affect Disord, 246, pp.355~360 (2019)
  80. Yee KOK, "Ictal electroencephalogram visual pattern recognition of seizure adequacy during electroconvulsive therapy treatment : a step-by-step approach", Malays J Med Sci, 30, pp.83~89 (2023)
  81. Jelovac A, "Relapse following successful electroconvulsive therapy for major depression : a meta-analysis", Neuropsychopharmacology, 38, pp.2467~2474 (2013)
  82. Lisanby SH, "Toward individualized post-electroconvulsive therapy care: piloting the symptom-titrated, algorithm-based longitudinal ECT (STABLE) intervention", J ECT, 24, pp.179~182 (2008)
  83. Lambrichts S, "Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis", Acta Psychiatr Scand, 143, pp.294~306 (2021)
  84. Janjua AU, "The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy(ECT)", CNS Drugs, 34, pp.509~520 (2020)
  85. Pettinati HM, "Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT", Am J Psychiatry, 147, pp.1029~1035 (1990)
  86. Boylan LS, "Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors", J ECT, 16, pp.3~18 (2000)
  87. Bailine SH, "Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety", Convuls Ther, 10, pp.65~68 (1994)
  88. Krystal AD, "The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient", J ECT, 14, pp.5~14 (1998)
  89. Ueda S, "Augmentation of seizure induction in electroconvulsive therapy", Jpn J Gen Hosp Psychiatry, 22, pp.153~161 (2010)
  90. Suzuki K, "Panic attack associated with flumazenil at electroconvulsive therapy session", J ECT, 25, pp.145~ (2009)
  91. "Guideline: the administration of electroconvulsive therapy"[URL]
  92. van Waarde JA, "Clinical predictors of seizure threshold in electroconvulsive therapy : a prospective study", Eur Arch Psychiatry Clin Neurosci, 263, pp.167~175 (2013)
  93. Ranck JB Jr, "Which elements are excited in electrical stimulation of mammalian central nervous system : a review", Brain Res, 98, pp.417~440 (1975)
  94. Nowak LG, "Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments", Exp Brain Res, 118, pp.489~500 (1998)
  95. Peterchev AV, "Electroconvulsive therapy stimulus parameters : rethinking dosage", J ECT, 26, pp.159~174 (2010)
  96. Liberson WT, "Time factors in electric convulsive therapy", Yale J Biol Med, 17, pp.571~578 (1945)
  97. Liberson WT., "New possibilities in electric convulsive therapy: “brief stimuli” technique. Preliminary report", Dig Neurol Psychiatry, 92, pp.368~369 (1944)
  98. Weaver LA Jr, "Studies in brief-pulse electroconvulsive therapy: the voltage threshold, interpulse interval, and pulse polarity parameters", Biol Psychiatry, 17, pp.1131~1143 (1982)
  99. Bai S, "Comparison of three right-unilateral electroconvulsive therapy montages", Proceedings of the 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), pp.819~822 (2013), IEEE
  100. Swartz CM, "Rational electroconvulsive therapy electrode placement", Psychiatry(Edgmont), 2, pp.37~43 (2005)
  101. Goldman D, "Brief stimulus electric shock therapy", J Nerv Ment Dis, 110, pp.36~45 (1949)
  102. Lancaster NP, "Unilateral electro-convulsive therapy", J Ment Sci, 104, pp.221~227 (1958)
  103. d’Elia G, "Unilateral electroconvulsive therapy", Acta Psychiatr Scand Suppl, 215, pp.1~98 (1970)
  104. Abrams R, "Clinical experiences with multiple electroconvulsive treatments", Compr Psychiatry, 13, pp.115~121 (1972)
  105. Letemendia FJ, "Therapeutic advantage of bifrontal electrode placement in ECT", Psychol Med, 23, pp.349~360 (1993)
  106. Fink M, "Convulsive therapy : theory and practice" (1979), Raven Press Ltd
  107. "Brain Stimul", 2013, 403~408
  108. Spellman T, "Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction", Neuropsychopharmacology, 34, pp.2002~2010 (2009)
  109. Rosa MA, "Frontomedial electrode placement with low current amplitude : a case report", J ECT, 28, pp.146~ (2012)
  110. Lee WH, "Comparison of electric field strength and spatial distribution of electroconvulsive therapy and magnetic seizure therapy in a realistic human head model", Eur Psychiatry, 36, pp.55~64 (2016)
  111. Steele JD, "Fronto-medial electrode placement for electroconvulsive treatment of depression", Front Neurosci, 16, pp.1029683~ (2022)
  112. Kellner CH, "Dosing methods in electroconvulsive therapy(ECT) : towards the modal ECT technique", Nord J Psychiatry, 76, pp.159~161 (2022)
  113. Bailine SH, "Comparison of bifrontal and bitemporal ECT for major depression", Am J Psychiatry, 157, pp.121~123 (2000)
  114. Ranjkesh F, "Bifrontal versus right unilateral and bitemporal electroconvulsive therapy in major depressive disorder", J ECT, 21, pp.207~210 (2005)
  115. Semkovska M, "Unilateral brief-pulse electroconvulsive therapy and cognition: effects of electrode placement, stimulus dosage and time", J Psychiatr Res, 45, pp.770~780 (2011)
  116. UK ECT Review Group, "Efficacy and safety of electroconvulsive therapy in depressive disorders : a systematic review and meta-analysis", Lancet, 361, pp.799~808 (2003)
  117. Loo CK, "A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT", Int J Neuropsychopharmacol, 11, pp.883~890 (2008)
  118. McCormick LM, "Relative ineffectiveness of ultrabrief right unilateral versus bilateral electroconvulsive therapy in depression", J ECT, 25, pp.238~242 (2009)
  119. Lapidus KA, "When to switch from unilateral to bilateral electroconvulsive therapy", J ECT, 27, pp.244~246 (2011)
  120. McLoughlin DM, "Response to Kellner and Farber : addressing crossover of high-dose right unilateral ECT to bitemporal ECT", Am J Psychiatry, 173, pp.731~732 (2016)
  121. Kawashima H, "Successful switch from bilateral brief pulse to right unilateral ultrabrief pulse electroconvulsive therapy after failure to induce seizures", Neuropsychiatr Dis Treat, 14, pp.607~610 (2018)
  122. Eda M, "When to switch from bilateral to unilateral electroconvulsive therapy : a simple way to elicit seizures in high seizure threshold cases", Neuropsychopharmacol Rep, 39, pp.36~40 (2019)
  123. 강석기, "전기경련치료에 대한 정신건강의학과 의료진의 인식 및 태도 조사", 생물정신의학, 30(2), pp.66~73 (2023), 대한생물정신의학회[DOI]
  124. Swartz CM, "Efficiency of the stimulus characteristics of ECT", Am J Psychiatry, 157, pp.1504~1506 (2000)
  125. Bai S, "A computational model of direct brain stimulation by electroconvulsive therapy", Annu Int Conf IEEE Eng Med Biol Soc, 2010, pp.2069~2072 (2010)
  126. Sienaert P, "Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression : cognitive side-effects", J Affect Disord, 122, pp.60~67 (2010)
  127. Kawashima H, "Elongation of pulse width as an augmentation strategy in electroconvulsive therapy", Neuropsychiatr Dis Treat, 10, pp.2009~2014 (2014)
  128. Krystal AD, "Effect of ECT treatment number on the ictal EEG", Psychiatry Res, 62, pp.179~189 (1996)
  129. Gaines GY 3rd, "Electroconvulsive therapy and anesthetic considerations", Anesth Analg, 65, pp.1345~1356 (1986)
  130. Wagner KJ, "Guide to anaesthetic selection for electroconvulsive therapy", CNS Drugs, 19, pp.745~758 (2005)
  131. Fredman B, "Anesthesia for electroconvulsive therapy : effects of propofol and methohexital on seizure activity and recovery", Anesth Analg, 79, pp.75~79 (1994)
  132. Modica PA, "Pro-and anticonvulsant effects of anesthetics(part I)", Anesth Analg, 70, pp.303~315 (1990)
  133. Katzung BG., "Basic and clinical pharmacology", pp.406~407 (2006), McGraw-Hill
  134. Janouschek H, "Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders", J Psychiatr Res, 47, pp.686~693 (2013)
  135. Abdollahi MH, "Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double-blind controlled clinical trial", J ECT, 28, pp.10~13 (2012)
  136. Baer GA, "Registration of raw data is a must when estimating depth of anaesthesia via EEG indices", Acta Anaesthesiol Scand, 50, pp.1306~ (2006)[DOI]
  137. Gombar S, "The bispectral electroencephalogram during modified electroconvulsive therapy under propofol anesthesia : relation with seizure duration and awakening", J ECT, 27, pp.114~118 (2011)
  138. Nishihara F, "Adjustment of anaesthesia depth using bispectral index prolongs seizure duration in electroconvulsive therapy", Anaesth Intensive Care, 32, pp.661~665 (2004)
  139. Ochiai R, "Bispectral index as an indicator of seizure inducibility in electroconvulsive therapy under thiopental anesthesia", Anesth Analg, 98, pp.1030~1035 (2004)
  140. Sartorius A, "ECT anesthesia : the lighter the better?", Pharmacopsychiatry, 39, pp.201~204 (2006)
  141. Suzuki M, "Effect of ketamine on bispectral index and levels of sedation", J Clin Monit Comput, 14, pp.373~ (1998)
  142. Faraoni D, "Ketamine has no effect on bispectral index during stable propofol-remifentanil anaesthesia", Br J Anaesth, 102, pp.336~339 (2009)
  143. Taylor R, "Effects of the anaesthetic-ECT time interval and ventilation rate on seizure quality in electroconvulsive therapy : a prospective randomised trial", Brain Stimul, 13, pp.450~456 (2020)
  144. Gálvez V, "Does remifentanil improve ECT seizure quality?", Eur Arch Psychiatry Clin Neurosci, 266, pp.719~724 (2016)
  145. Jorgensen A, "The influence of the anesthesia-to-stimulation time interval on seizure quality parameters in electroconvulsive therapy", J Affect Disord, 231, pp.41~43 (2018)
  146. Tan XW, "Association of Anaesthesia-ECT time interval with ECT clinical outcomes : a retrospective cohort study", J Affect Disord, 285, pp.58~62 (2021)
  147. Lihua P, "Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy(ECT)in adult patients with depression", Cochrane Database Syst Rev, 2014, pp.CD009763~ (2014)
  148. Takekita Y, "Anesthetic agents in electroconvulsive therapy", Jpn J Biol Psychiatry, 29, pp.151~156 (2018)
  149. Fond G, "A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness", tolerability profile in electroconvulsive therapy for major depression, 2016, pp.6, 19847~
  150. Saffer S, "Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone", J ECT, 14, pp.89~93 (1998)
  151. Doenicke AW, "Reducing myoclonus after etomidate", Anesthesiology, 90, pp.113~119 (1999)
  152. Ball C, "Intravenous induction agents : etomidate", Anaesth Intensive Care, 30, pp.405~ (2002)
  153. Singh PM, "Evaluation of etomidate for seizure duration in electroconvulsive therapy : a systematic review and meta-analysis", J ECT, 31, pp.213~225 (2015)
  154. Erdogan Kayhan G, "Ketofol(mixture of ketamine and propofol)administration in electroconvulsive therapy", Anaesth Intensive Care, 40, pp.305~310 (2012)
  155. Berman RM, "Antidepressant effects of ketamine in depressed patients", Biol Psychiatry, 47, pp.351~354 (2000)
  156. Ghasemi M, "Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder", Psychiatry Res, 215, pp.355~361 (2014)
  157. Okamoto N, "Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression : comparing ketamine and propofol anesthesia", J ECT, 26, pp.223~227 (2010)
  158. Kellner CH, "Ketamine and ECT : better alone than together?", Lancet Psychiatry, 4, pp.348~349 (2017)
  159. Cobb K, "Ketamine and electroconvulsive therapy : so happy together?", Curr Opin Anaesthesiol, 31, pp.459~462 (2018)
  160. Newport DJ, "Ketamine and other NMDA antagonists : early clinical trials and possible mechanisms in depression", Am J Psychiatry, 172, pp.950~966 (2015)
  161. Angst J, "ECT-induced and drug-induced hypomania", Convuls Ther, 8, pp.179~185 (1992)
  162. Bailine S, "Electroconvulsive therapy is equally effective in unipolar and bipolar depression", Acta Psychiatr Scand, 121, pp.431~436 (2010)
  163. McGirr A, "A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy : efficacy and tolerability", J Psychiatr Res, 62, pp.23~30 (2015)
  164. Anderson IM, "Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (ketamine-ECT): a multicentre, double-blind, randomised, parallelgroup, superiority trial", Lancet Psychiatry, 4, pp.365~377 (2017)
  165. Ren L, "Ketamine in electroconvulsive therapy for depressive disorder : a systematic review and metaanalysis", J Psychiatr Res, 104, pp.144~156 (2018)
  166. Rhee TG, "Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode : a systematic review and meta-analysis", JAMA Psychiatry, 79, pp.1162~1172 (2022)
  167. Mathew SJ, "Electroconvulsive therapy (ECT) vs. ketamine in patients with treatment-resistant depression: the ELEKT-D study protocol", Contemp Clin Trials, 77, pp.19~26 (2019)
  168. Yalcin S, "Ketofol in electroconvulsive therapy anesthesia : two stones for one bird", J Anesth, 26, pp.562~567 (2012)
  169. Wang X, "Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder", J ECT, 28, pp.128~132 (2012)
  170. Gaddam NR, "A comparative study of propofol, thiopentone sodium, and ketofol as induction agents for electro convulsive therapy", J Anaesthesiol Clin Pharmacol, 37, pp.554~560 (2021)
  171. Yazdi B, "Investigating the effects of ketofol and the combination of remifentanil and propofol on the duration of the convulsion and haemodynamics of psychotic patients in electroconvulsive therapy : a randomised clinical study", Adv Hum Biol, 11, pp.176~180 (2021)
  172. Gurel SC, "The superiority of ketofol and etomidate against propofol or thiopental anesthesia for ECT", Asian J Psychiatr, 72, pp.103090~ (2022)
  173. Joshi CP, "Comparison of ketofol(ketamine and propofol)and etomidate in electro convulsive therapy : a double-blinded randomized controlled trial", Indian Anaesth Forum, 22, pp.73~78 (2021)
  174. Kellner CH, "Electroconvulsive therapy anesthesia technique : minimalist versus maximally managed", J ECT, 29, pp.153~155 (2013)
  175. Chung IW, "Principles and practice of electroconvulsive therapy" (2019), Seoul National University Publication Center
  176. Chen ST, "Remifentanil : a review of its use in electroconvulsive therapy", J ECT, 27, pp.323~327 (2011)
  177. Nishikawa K, "Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia", J Anesth, 25, pp.29~33 (2011)
  178. Egan TD, "The pharmacokinetics of the new short-acting opioid remifentanil(GI87084B)in healthy adult male volunteers", Anesthesiology, 79, pp.881~892 (1993)
  179. Bridenbaugh RH, "Multiple monitored electroconvulsive treatment of schizophrenia", Compr Psychiatry, 13, pp.9~17 (1972)
  180. Haeck M, "Electroconvulsive therapy can benefit from controlled hyperventilation using a laryngeal mask", Eur Arch Psychiatry Clin Neurosci, 261(Suppl 2), pp.S172~S176 (2011)[DOI]
  181. Weiner RD, "The psychiatric use of electrically induced seizures", Am J Psychiatry, 136, pp.1507~1517 (1979)
  182. Stripp TK, "Anaesthesia for electroconvulsive therapy-new tricks for old drugs : a systematic review", Acta Neuropsychiatr, 30, pp.61~69 (2018)
  183. Swartz CM, "Theophylline reversal of electroconvulsive therapy(ECT)seizure inhibition", Psychosomatics, 32, pp.47~51 (1991)
  184. Sienaert P, "Anticonvulsants during electroconvulsive therapy : review and recommendations", J ECT, 23, pp.120~123 (2007)
  185. Smith HS, "Perioperative medicine", pp.179~185 (2011), Springer
  186. Boison D, "Methylxanthines. Handbook of experimental pharmacology", pp.251~266 (2011), Springer Berlin Heidelberg
  187. Wada K, "Oral theophylline augmentation for patients with missed or inadequate seizures with electroconvulsive therapy", Asian J Psychiatr, 73, pp.103148~ (2022)
  188. Peters SG, "Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy", Mayo Clin Proc, 59, pp.568~570 (1984)
  189. Devanand DP, "Status epilepticus following ECT in a patient receiving theophylline", J Clin Psychopharmacol, 8, pp.153~ (1988)
  190. Shapira B, "Potentiation of seizure length and clinical response to electroconvulsive therapy by caffeine pretreatment : a case report", Convuls Ther, 1, pp.58~60 (1985)
  191. Ancill RJ, "Oral caffeine augmentation of ECT", Am J Psychiatry, 149, pp.137~ (1992)
  192. Jaffe R, "Oral versus intravenous caffeine augmentation of ECT", Am J Psychiatry, 149, pp.1610~ (1992)
  193. 허진산, "Caffeine 전처치를 시행한 전기경련요법", Korean Journal of Anesthesiology, 50(2), pp.236~ (2006), 대한마취통증의학회
  194. Coffey CE, "Augmentation of ECT seizures with caffeine", Biol Psychiatry, 22, pp.637~649 (1987)
  195. Loo C, "Augmentation strategies in electroconvulsive therapy", J ECT, 26, pp.202~207 (2010)
  196. Bozymski KM, "Caffeine sodium benzoate for electroconvulsive therapy augmentation", J ECT, 34, pp.233~239 (2018)
  197. Scheinin B, "Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl", Br J Anaesth, 68, pp.126~131 (1992)
  198. Jaakola ML, "Dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery", Br J Anaesth, 68, pp.570~575 (1992)
  199. Peden CJ, "The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil", Anaesthesia, 56, pp.408~413 (2001)
  200. 이성헌, "Dexmedetomidine: present and future directions", Korean Journal of Anesthesiology, 72(4), pp.323~330 (2019), 대한마취통증의학회
  201. McCall WV, "Antihypertensive medications and ECT", Convuls Ther, 9, pp.317~325 (1993)
  202. Sundsted KK, "Preanesthesia medical evaluation for electroconvulsive therapy : a review of the literature", J ECT, 30, pp.35~42 (2014)
  203. van den Broek WW, "Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study", Br J Anaesth, 83, pp.271~274 (1999)
  204. Ahn YM, "Principles and practice of electroconvulsive therapy", pp.77~102 (2019), Seoul National University Publication Center
  205. Howie MB, "Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy", Anesth Analg, 71, pp.384~388 (1990)
  206. Castelli I, "Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy", Anesth Analg, 80, pp.557~561 (1995)
  207. Tavares AR Jr, "Medical evaluation before electroconvulsive therapy", N Engl J Med, 360, pp.2791~ (2009)[DOI]
  208. Hermida AP, "The cardiovascular side effects of electroconvulsive therapy and their management", J ECT, 38, pp.2~9 (2022)
  209. Boere E, "Beta-blocking agents during electroconvulsive therapy : a review", Br J Anaesth, 113, pp.43~51 (2014)
  210. Avramov MN, "Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy", J Clin Anesth, 10, pp.394~400 (1998)
  211. Zhang Y, "The use of nicardipine for electroconvulsive therapy : a dose-ranging study", Anesth Analg, 100, pp.378~381 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (7건)